Vuzix Q2 Revenue Falls 14% as R&D Spending Climbs
VUZI sits 30% above its 52-week low of $1.83.
Summary
Vuzix reported Q2 revenue down 14% year-over-year, with product sales falling 15%, while R&D spending rose on new product development and headcount. Net loss narrowed slightly to $0.09 per share from $0.10. The company delivered initial Ultralite Pro glasses to Amazon for testing and expanded M400 deployments. This follows a 12% revenue decline in Q1 and continued cash burn, but management sees AI-driven demand momentum. The stock trades at $2.38, well below the $6.00 median price target.
At the time of this announcement, VUZI was trading at $2.38 on NASDAQ in the Technology sector, with a market capitalization of approximately $219.5M. The 52-week trading range was $1.83 to $5.62. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Reuters.